Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer ...Middle East

BEIJING, SHANGHAI and BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combination of Jacobio's CD73 monoclonal antibody JAB-BX102 in combination with Merck & Co.,...

Hence then, the article about jacobio announces clinical collaboration to evaluate cd73 monoclonal antibody jab bx102 in combination with keytruda pembrolizumab for patients with cancer was published today ( Wednesday 22/03/2023 - 08:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer )

Also on site :

• ‘Harry Potter’ Series Star Paapa Essiedu Says He’s Received Death Threats Over Snape Casting: ‘I’ve Been Told, “Quit or I’ll Murder You”’
• Dozens injured after missile strike in Southern Israel
• Door Cam Catches Healthcare Worker After 7-Hour Shift—Footage Says It All